How do I find out if I qualify for a recurrent b acute lymphoblastic leukemia study in North Carolina?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in North Carolina to take part?

Not necessarily. These studies have a site in North Carolina, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a recurrent b acute lymphoblastic leukemia trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · North Carolina

Recurrent B Acute Lymphoblastic Leukemia clinical trials in North Carolina

We’re tracking 3 recruiting recurrent b acute lymphoblastic leukemia studies with a site in North Carolina — including Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.

Recruiting studies in North Carolina

NCT03739814RecruitingPhase 2
Test inotuzumab, blinatumomab, and possibly ponatinib for CD22 ALL
This Phase 2 study tests a combination of medicines (inotuzumab ozogamicin and blinatumomab), with or without ponatinib, for people with CD22-positive B-cell acute lymphoblastic leukemia (ALL). It aims to improve remission and control leukemia cells, including in the bone marrow.
Chapel Hill, North CarolinaAges 18 years+
NCT04315324RecruitingPhase 1/Phase 2
Test drug OBI-3424 for relapsed T-cell blood cancer
This trial tests OBI-3424, an investigational medicine, in adults and children with relapsed or hard-to-treat T-cell acute leukemia or certain T-cell lymphoma. It may help by shrinking cancer when standard treatments have not worked.
Durham, North CarolinaAges 12 years+
NCT04546399RecruitingPhase 2
Blinatumomab with or without nivolumab for first relapse ALL
This study compares blinatumomab alone versus blinatumomab plus nivolumab in young people whose B-cell ALL has returned for the first time. It aims to see whether adding nivolumab improves control of the leukemia after relapse.
Asheville, North CarolinaAges 1–30

Recurrent B Acute Lymphoblastic Leukemia trials by city in North Carolina

Raleigh–Durham

Where these studies are running in North Carolina

Institutions with a site for the recruiting recurrent b acute lymphoblastic leukemia studies listed above.

Duke University Medical Center · 3 studies
East Carolina University · 2 studies
UNC Lineberger Comprehensive Cancer Center · 2 studies
Wake Forest University Health Sciences · 2 studies
Carolinas Medical Center/Levine Cancer Institute
Mission Hospital

What taking part in a recurrent b acute lymphoblastic leukemia study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Recurrent B Acute Lymphoblastic Leukemia trials in other states

Common questions

Are there recurrent b acute lymphoblastic leukemia clinical trials in North Carolina?: Yes. We're currently tracking 3 recruiting recurrent b acute lymphoblastic leukemia studies with a site in North Carolina, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a recurrent b acute lymphoblastic leukemia study in North Carolina?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in North Carolina to take part?: Not necessarily. These studies have a site in North Carolina, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a recurrent b acute lymphoblastic leukemia trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New recurrent b acute lymphoblastic leukemia studies open in North Carolina regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.